Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function. The company was founded in 2007 and is based in Newton, Massachusetts, United States.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Stealth BioTherapeutics Corp - ADR market cap is $20.98M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Stealth BioTherapeutics Corp - ADR 52 week high is $1.00 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Stealth BioTherapeutics Corp - ADR 52 week low is $0.1621 as of November 17, 2026.
Stealth BioTherapeutics Corp - ADR stock price today is $0.32.
Stealth BioTherapeutics Corp - ADR stock price yesterday was $0.3244.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Stealth BioTherapeutics Corp - ADR's P/E ratio is -0.35.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Stealth BioTherapeutics Corp - ADR P/B ratio is -0.0305.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Stealth BioTherapeutics Corp - ADR 50-day moving average is $0.3156.